Association between Helicobacter pylori infection and pancreatic cancer

Oncology

Volumn 55, Issue 1, 1997, Pages 16-19

  Raderer, Markus ^a,b   Wrba, Friedrich ^a   Kornek, Gabriela ^a   Maca, Thomas ^a   Koller, Dieter Y ^a   Weinlaender, Georg ^a   Hejna, Michael ^a   Scheithauer, Werner ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Helicobacter pylori; Pancreatic cancer

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; SEROPREVALENCE; STATISTICAL ANALYSIS; STOMACH CANCER; ADENOCARCINOMA; BLOOD; CASE CONTROL STUDY; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PANCREAS TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 0030684781     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011830     Document Type: Article

References (40)

1. Brennan MF, Kinsella TJ, Casper ES: Cancer of the pancreas; in De Vita V, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott 1993, pp 849-877.
2. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
3. Vutuc C: Krebsmortalitä t und Krebsinzidenz; in Pirker R, Fiegl M, Huber (eds): Klinische Onkologie. Wien, Facultas, 1996, pp 13-19.
4. National Cancer Institute: Annual cancer statistics review 1973-1988 (NIH publication No. 91-2789). Bethesda, Department of Health and Human Services, 1991.
5. Friedman GD, van den Eeden SK: Risk factors for pancreatic cancer: An exploratory study. Int J Epidemiol 1993; 22: 30-37.
6. Farrow DC, Davis S: Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol, coffee and diet. Int J Cancer 1990; 45: 816-820.
7. Ghadirian P, Simard A, Baillargeon J: Tobacco, alcohol and coffee and cancer of the pancreas. A population-based case control study in Quebec, Canada. Cancer 1991; 67: 2664-2670.
8. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, Brown LM, Greenberg RS, Hayes RB, Swanson GM, Wacholder S, Schwartz AG, Liff JM, Pottern LM: Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510-1516.
9. Birt DF, Stepan KR, Pour PM: Interaction of dietary fat and protein on pancreatic carcinogenesis in Syrian golden hamsters. J Natl Cancer Inst 1983; 71: 355-360.
10. Gordis L: Consumption of methylxanthine-containing beverages and risk of pancreatic cancer. Cancer Lett 1990; 52: 1-12.
11. Howe GR, Jain M, Miller AB: Dietary factors and risk of pancreatic cancer: Results of a Canadian population-based case-control study. Int J Cancer 1990; 45: 604-608.
12. Offerhaus GJA, Tersmette AC, Tersmette KWF, Tytgat GNJ, Hoedemaker PJ, Vandenbroucke JP: Gastric, pancreatic and colorectal carcinogenesis following remote peptide ulcer surgery. Mod Pathol 1988; 352-356.
13. Smith JP, Solomon TE, Bagheri S, Kramer S: Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990; 35: 1377-1384.
14. Taylor PR, Dowling RH, Palmer TJ, Hanley TC, Murphy GM, Mason RC, McColl I: Induction of pancreatic tumours by long-term duodenogastric reflux. Gut 1989; 30: 1596-1600.
15. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 1994; 89: 116-128.
16. Parsonnet J, Friedman GD, Vandersteen DP: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
17. The EUROGAST Study Group: An association between Helicobacter pylori infection and gastric cancer: An international study. Lancet 1993; 341: 1359-1362.
18. Wotherspoon AC, Ortiz-Hidalgo C, Falzon ME, Isaacson PC: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
19. Hussell T, Isaacson PG, Crabtree JE, Spencer J: Cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-574.
20. Nightingale TE, Gruber J: Helicobacter and human cancer. J Natl Cancer Inst 1994; 86: 1505-1509.
21. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagishima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benveniste RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, Rice JM: Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86: 1222-1227.
22. Talley NJ, Kost L, Haddad A, Zinsmeister AR: Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992; 30: 3146-3150.
23. The EUROGAST Study Group: Epidemiology of, and risk factors for, Helicobacter pylori infection among 3,194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-1676.
24. Megraud F: Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22: 73-88.
25. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739.
26. Lin JT, Wang JT, Wang TH, Wu MS, Chen CJ: Helicobacter pylori infection in early and advanced gastric cancer: A seroprevalence study in 143 Taiwanese patients. Hepatogastroenterology 1993; 40: 596-599.
27. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat M, Forde KA: Helicobacter pylori seroprevalence and colorectal neoplasia: Evidence against an association. J Natl Cancer Inst 1995; 87: 762-763.
28. Jiang SJ, Liu WZ, Zhang DZ, et al: Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol 1987; 22: 553-558.
29. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740.
30. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Shi TY: Helicobacter pylori causes hyperproliferation of the gastric epithelium: Pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-1875.
31. Correa P: Is gastric carcinoma an infectious disease? N Engl J Med 1991; 325: 1170-1171.
32. Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J: Antral Helicobacter pylori, hypergastrinemia, and duodenal ulcers: Effect of eradicating the organism. BMJ 1989; 299: 1504-1505.
33. Graham DY, Opekum A, Lew GM, Evans DJ Jr, Klein PD, Evans DC: Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394-398.
34. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.
35. Johnson LR: Effects of gastrointestinal hormones on pancreatic growth. Cancer 1983; 47: 1640-1645.
36. Dembinski AB, Johnson LR: Stimulation of pancreatic growth by secretin, caerulein and pentagastrin. Endocrinology 1980; 106: 323-328.
37. Townsend CM, Franklin RB, Watson LC, Glass EJ, Thompson JC: Stimulation of pancreatic cancer growth by caerulein and secretin. Surg Forum 1981; 32: 228-229.
38. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 1995; 333: 4127-4132.
39. Bateson MC: Cigarette smoking and Helicobacter pylori infection. Postgrad Med J 1993; 69: 41-44.
40. Office of Population Censuses and Surveys: Classification of Occupations. London, Government Statistical Services, 1980.